1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Bariatric Surgery: Global Markets for Services and Devices

Bariatric Surgery: Global Markets for Services and Devices

  • February 2016
  • -
  • BCC Research
  • -
  • 165 pages

This BCC Research report looks at current and future markets, and analyzes technological, demographic and economic developments that may have a long-term impact on the size and structure of the bariatric surgery market for services and devices. Market projections provided through 2020.

REPORT HIGHLIGHTS

The global market for bariatric surgery devices was worth more than $1.2 billion in 2014. The market reached $1.4 billion in 2015 and a projected $2.2 billion by 2020, increasing at a compound annual growth rate (CAGR) of 9.8% from 2015 through 2020.

This report provides:

- An overview of the global market for services and devices used in the bariatric surgery sector.
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.
- Discussion on types of obesity, etiology and pathophysiology, risk factors, economic burden, epidemiology, and obesity treatment and management.
- An examination of the types and the criteria for bariatric surgeries, along with common complications and the average cost associated with post-surgical complications.
- A historical perspective on and the current scenario for bariatric surgery procedure.
- An evaluation of the current clinical challenges, unmet needs, and future outlook.
- Profiles of major players in the industry.

SCOPE OF THE REPORT

This report is an analytical business tool with the primary purpose of describing the bariatric surgery and the global market for services and devices. The format of the study is organized around the following topics.
- Detailed study around diseases like obesity and diabetes.
- Major types of bariatric procedures (gastric bypass, gastric banding and sleeve gastrectomy), complications and relevant devices (e.g., implanted devices, gastric removal devices and gastric bypass devices).
- Procedure trends and cost estimates (one-time procedure cost excluding follow-up outpatient monitoring cost).
- Regulatory structure.
- Market characterization, unmet need, market size and segmentation, including historical data on sales by application, product type, end-user group and geographical market.
- Market drivers and restraints.
- Detailed market projections through 2020.
- Competition and market shares.
- Reimbursement.
- Marketed and pipeline (R&D) products along with description, regulatory status and clinical trials.
- Observations and conclusions regarding the future of bariatric surgery market for services and devices.
- Profiles of market participants and associations.

Table Of Contents

Bariatric Surgery: Global Markets for Services and Devices
CHAPTER 1 INTRODUCTION 2
BARIATRIC SURGERY 2
STUDY BACKGROUND 2
STUDY GOALS AND OBJECTIVES 3
INTENDED AUDIENCE 3
SCOPE OF THE REPORT 4
METHODOLOGY AND INFORMATION SOURCES 4
ANALYST'S CREDENTIALS 5
RELATED BCC RESEARCH REPORTS 5
BCC RESEARCH WEBSITE 5
DISCLAIMER 5
CHAPTER 2 EXECUTIVE SUMMARY 7
EXECUTIVE SUMMARY 7
SUMMARY TABLE GLOBAL MARKET FOR BARIATRIC SURGERY BY REGION,
THROUGH 2020 ($ MILLIONS) 7
SUMMARY FIGURE GLOBAL MARKET FOR BARIATRIC SURGERY BY REGION,
2014-2020 ($ MILLIONS) 7
CHAPTER 3 OVERVIEW OF OBESITY 10
DISEASE OVERVIEW 10
COMMON TOOLS TO DIAGNOSE OBESITY 10
BMI 10
TABLE 1 BMI CALCULATION 10
Waist Circumference 10
TYPES OF OBESITY 11
TABLE 2 BMI CATEGORIES BASED ON INCREASING HEALTH RISKS 11
ETIOLOGY AND PATHOPHYSIOLOGY 11
FIGURE 1 ENERGY BALANCE, 2014 12
RISK FACTORS 13
ECONOMIC BURDEN 14
EPIDEMIOLOGY 15
TABLE 3 GLOBAL OBESE POPULATION AND SEVERE OBESE POPULATION VS.
GENERAL POPULATION, THROUGH 2014 (MILLIONS) 16
FIGURE 2 GLOBAL OBESE POPULATION AND SEVERE OBESE POPULATION, 2008
AND 2014 (% OF GLOBAL GENERAL POPULATION) 16
TABLE 4 U.S. OBESITY AND SEVERE OBESITY VS. GENERAL POPULATION,
THROUGH 2014 (MILLIONS) 17
OBESITY TREATMENT AND MANAGEMENT 18
GOALS OF WEIGHT LOSS AND MANAGEMENT 18
WEIGHT MANAGEMENT 18
DIETARY THERAPY 19
PHYSICAL ACTIVITY 19
BEHAVIORAL THERAPY 20
COMBINED THERAPY 20
PHARMACOTHERAPY 20
BARIATRIC SURGERY (WEIGHT-LOSS SURGERY) 21
CHAPTER 4 OBESITY AND TYPE 2 DIABETES 23
OBESITY AND DIABETES 23
DIABETES MELLITUS (DM) 23
GESTATIONAL DIABETES 23
LATENT AUTOIMMUNE DIABETES IN ADULTS (LADA) 23
FIGURE 3 GLOBAL DIABETES TYPES (% OF TOTAL DIABETES) 24
TYPE 2 DIABETES: ETIOLOGY AND PATHOPHYSIOLOGY 24
DISEASE SYMPTOMS AND RISK FACTORS 25
EPIDEMIOLOGY 26
TABLE 5 GLOBAL DIABETES PREVALENCE, THROUGH 2030 (BILLIONS/%/MILLIONS) 27
TREATMENT AND MANAGEMENT OPTIONS 27
LIFESTYLE CHANGES 27
ANTIOBESITY MEASURES (PHARMACOLOGIC AGENTS) 28
DIABETES MEDICATIONS AND INSULIN THERAPY 28
BARIATRIC SURGERY 29
MARKET BURDEN 29
CHAPTER 5 OVERVIEW OF BARIATRIC PROCEDURES 32
GENERAL OVERVIEW 32
CRITERIA FOR BARIATRIC SURGERY 32
LAPAROSCOPIC SURGERY VS. OPEN SURGERY 32
FIGURE 4 GLOBAL OPEN VS. LAPAROSCOPIC BARIATRIC SURGERY OCCURRENCE,
2014 (% OF TOTAL BARIATRIC PROCEDURES) 34
BARIATRIC SURGERY PREPARATION 34
DIET MONITORING 34
DIET CONSULTATION 35
PSYCHOLOGICAL CONSULTATION 35
SCREENING BLOOD TESTS 35
INSURANCE COVERAGE 35
TYPES OF BARIATRIC SURGERIES 36
TABLE 6 TYPES OF BARIATRIC SURGERIES 36
MALABSORPTIVE 36
Biliopancreatic Diversion (BPD) 36
Advantages 37
Disadvantages 37
Biliopancreatic Diversion with a Duodenal Switch (BPD-DS) 38
Extended (Distal) Roux-en-Y Gastric Bypass (RYGBP-E) 38
Mini Gastric Bypass 38
Advantages of Malabsorptive Procedures 38
Disadvantages of Malabsorptive Procedures 39
RESTRICTIVE PROCEDURES 39
Sleeve Gastrectomy (SG) 39
Vertical Sleeve Gastrectomy (VSG) 39
Adjustable Gastric Banding (AGB) 40
Gastric Balloons 40
Advantages of Restrictive Procedures 40
Disadvantages of Restrictive Procedures 41
COMBINED RESTRICTIVE/MALABSORPTIVE 42
Gastric Bypass 42
Roux-en-Y Gastric Bypass (RYGB) 43
Advantages of Gastric Bypass 43
Disadvantages of Gastric Bypass 44
NEW BARIATRIC PROCEDURES 44
PRIMARY OBESITY SURGERY ENDOLUMINAL (POSE) PROCEDURE 44
Procedure Design 45
Clinical Trials 46
RESTORATIVE OBESITY SURGERY ENDOSCOPIC (ROSE) PROCEDURE 46
Procedure 46
Clinical Trials 47
Advantages of ROSE Procedure 47
ROSE Procedure: Procedure Cost 47
BENEFITS OF BARIATRIC SURGERY 47
RISKS AND COMPLICATIONS OF BARIATRIC SURGERY 51
PULMONARY EMBOLISM 51
GASTROINTESTINAL TRACT LEAK 51
BOWEL OBSTRUCTION (BLOCKAGES) 52
STRICTURE 52
BLEEDING 52
ULCER 53
GALLSTONES 53
INFECTIONS 53
CHRONIC NUTRITIONAL PROBLEMS 54
CONVERSION TO OPEN PROCEDURE 55
FAILURE OF WEIGHT LOSS 55
TOO MUCH WEIGHT LOSS 55
BODY IMAGE, EMOTIONAL LOSS AND DEPRESSION 56
NEUROPATHY 56
HYPOGLYCEMIA (LOW BLOOD SUGARS 56
KIDNEY FAILURE/STONES 57
COMPLICATIONS FROM ANESTHESIA 57
DEATH 57
OTHER COMPLICATIONS 57
BARIATRIC PROCEDURE HISTORIC AND CURRENT TRENDS 57
GLOBAL 57
TABLE 7 GLOBAL BARIATRIC PROCEDURES, THROUGH 2014 (NUMBER) 58
FIGURE 5 GLOBAL BARIATRIC PROCEDURE TYPES, 2014 (% OF ALL BARIATRIC
PROCEDURES) 58
FIGURE 6 GLOBAL BARIATRIC PROCEDURE BY REGION, 2014 (% OF GLOBAL
PROCEDURES) 59
NORTH AMERICA 60
TABLE 8 BARIATRIC PROCEDURE OCCURRENCE IN NORTH AMERICA, THROUGH
2014 (NO. OF PROCEDURES) 60
FIGURE 7 BARIATRIC PROCEDURE OCCURRENCE IN NORTH AMERICA, 2014 (% OF
ALL BARIATRIC PROCEDURES) 60
HLC153B - Bariatric Surgery: Global Markets for Services and Devices
Copyright © BCC Research, Wellesley MA USA, Website: www.bccresearch.com
TOPIC PAGE NO.
AVERAGE PROCEDURE COST OF BARIATRIC SURGERY 61
TABLE 9 AVERAGE COST OF BARIATRIC SURGERY BY PROCEDURE TYPE ($) 61
FACTORS AFFECTING BARIATRIC SURGERY COST 61
BARIATRIC SURGERY: COMPARATIVE ANALYSIS 62
TABLE 10 COMPARATIVE ANALYSIS OF BARIATRIC SURGERY 63
HISTORY OF BARIATRIC SURGERY 64
JAW WIRING 64
JEJUNOILEAL BYPASS 64
GASTRIC PARTITIONING 65
VERTICAL BAND GASTROPLASTY (VBG) 65
GASTRIC BALLOONS 65
CHAPTER 6 OVERVIEW OF BARIATRIC SURGERY DEVICES 67
BARIATRIC SURGERY DEVICES 67
GASTRIC BYPASS 67
GASTRIC REMOVAL DEVICES 67
IMPLANTED GASTRIC DEVICES 67
Gastric Bands 67
Intragastric Balloons (IGB) 67
TABLE 11 PRINCIPAL TYPES OF BARIATRIC SURGERY DEVICES 67
REGULATORY STATUS OF BARIATRIC SURGERY DEVICES 69
UNITED STATES 69
EUROPEAN UNION (EU) 71
JAPAN 73
OTHER ASIA 74
China 74
Hong Kong 74
Taiwan 74
India 75
END-USER SEGMENTS 75
CHAPTER 7 UNMET NEED FOR OBESITY AND DIABETES TYPE 2 77
CHAPTER 8 BARIATRIC SURGERY MARKET ASSESSMENT 80
BARIATRIC PROCEDURES AND SERVICES MARKET 80
GLOBAL 80
TABLE 12 GLOBAL BARIATRIC PROCEDURE OCCURRENCE BY TYPE, THROUGH 2020
(NUMBER) 81
FIGURE 8 GLOBAL BARIATRIC PROCEDURE OCCURRENCE BY TYPE, 2014 AND 2020
(% OF TOTAL BARIATRIC SURGERY) 81
TABLE 13 BARIATRIC PROCEDURE OCCURRENCE BY REGION, THROUGH 2020
(NUMBER) 82
FIGURE 9 BARIATRIC PROCEDURE OCCURRENCE BY REGION, 2014 AND 2020 (%
OF TOTAL BARIATRIC SURGERY) 82
NORTH AMERICA 83
TABLE 14 BARIATRIC PROCEDURE OCCURRENCE IN NORTH AMERICA, THROUGH
2020 (NUMBER) 84
FIGURE 10 BARIATRIC PROCEDURE OCCURRENCE IN NORTH AMERICA, 2014 AND
2020 (% OF TOTAL BARIATRIC SURGERY) 84
HLC153B - Bariatric Surgery: Global Markets for Services and Devices
Copyright © BCC Research, Wellesley MA USA, Website: www.bccresearch.com
TOPIC PAGE NO.
EUROPE 85
TABLE 15 BARIATRIC PROCEDURE OCCURRENCE IN EUROPE, THROUGH 2020
(NUMBER) 85
FIGURE 11 BARIATRIC PROCEDURE OCCURRENCE IN EUROPE, 2014 AND 2020 (%
OF TOTAL BARIATRIC SURGERY) 85
ASIA 86
TABLE 16 BARIATRIC PROCEDURE OCCURRENCE IN ASIA, THROUGH 2020
(NUMBER) 87
FIGURE 12 BARIATRIC PROCEDURE OCCURRENCE IN ASIA, 2014 AND 2020 (% OF
TOTAL BARIATRIC SURGERY) 87
PROJECTED TRENDS IN BARIATRIC SURGERY 88
BARIATRIC SURGERY DEVICES MARKET 88
GLOBAL BARIATRIC SURGERY DEVICE MARKET BY REGION 88
TABLE 17 GLOBAL BARIATRIC SURGERY DEVICE MARKET BY REGION, THROUGH
2020 ($ MILLIONS) 89
FIGURE 13 GLOBAL BARIATRIC SURGERY DEVICE MARKET BY REGION, 2014 AND
2020 (% OF TOTAL BARIATRIC SURGERY) 89
GLOBAL BARIATRIC SURGERY DEVICES MARKET BY TYPE OF DEVICE 90
North America 90
TABLE 18 NORTH AMERICAN BARIATRIC SURGERY MARKET BY DEVICE TYPE,
THROUGH 2020 ($ MILLIONS) 90
FIGURE 14 NORTH AMERICAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, 2014
AND 2020 (% OF TOTAL BARIATRIC SURGERY) 90
Asia 91
TABLE 19 ASIAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, THROUGH 2020 ($
MILLIONS) 92
FIGURE 15 ASIAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, 2014 AND 2020
(% OF TOTAL BARIATRIC SURGERY) 92
Europe 93
TABLE 20 EUROPEAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, THROUGH
2020 ($ MILLIONS) 93
FIGURE 16 EUROPEAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, 2014 AND
2020 (% OF TOTAL BARIATRIC SURGERY) 93
GLOBAL IMPLANTED BARIATRIC SURGERY DEVICES MARKET 95
TABLE 21 GLOBAL MARKET FOR IMPLANTED DEVICES, THROUGH 2020 ($ MILLIONS) 95
MARKET GROWTH DRIVERS AND RESTRAINTS 95
GROWTH DRIVERS 95
Global Obesity Epidemic 95
Diabetes Prevalence 96
Less Invasive/Noninvasive Procedures 96
Western Food Habits and Sedentary Lifestyles 96
Reimbursement 96
Increasing Awareness in Developed Nations 96
Medical Tourism 97
GROWTH RESTRAINTS 97
Lack of Awareness, Availability and Affordability in Developing
Nations 97
High Cost of Bariatric Surgery 97
Long Wait Time 97
Short-Term and Long-Term Complications 97
CHAPTER 9 COMPETITION AND MARKET SHARES 99
TABLE 22 GLOBAL BARIATRIC SURGERY MARKET SHARES BY COMPANY, 2014 ($
MILLIONS/%) 99
FIGURE 17 GLOBAL BARIATRIC SURGERY MARKET SHARES BY COMPANY, 2014 (%
OF TOTAL MARKET) 99
CHAPTER 10 MARKETED, ABANDONED AND PIPELINE PRODUCTS 102
MARKETED PRODUCTS 102
TABLE 23 KEY MARKETED PRODUCTS OF BARIATRIC SURGERY DEVICES 102
VBLOC THERAPY/MAESTRO RC SYSTEM 104
General Description 104
Clinical Trials 104
Procedure 104
RESHAPE INTEGRATED DUAL BALLOON SYSTEM 105
ORBERA INTRAGASTRIC BALLOON 105
GASTRISAIL GASTRIC POSITIONING SYSTEM 105
LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEM 106
REALIZE ADJUSTABLE GASTRIC BAND 106
ENSEAL 106
PERI-STRIPS DRY WITH VERITAS 107
ENDOPATH XCEL TROCAR 107
ECHELON FLEX POWERED ARTICULATING ENDOSCOPIC LINEAR CUTTERS 108
HARMONIC ACE SHEARS + ADAPTIVE TISSUE TECHNOLOGY 108
ENDO GIA RADIAL RELOAD WITH TRI-STAPLE TECHNOLOGY 109
Endo GIA Reload 109
ENDO STITCH ENDOSCOPIC SUTURING DEVICE 109
ENDOGASTRIC SOLUTIONS STOMAPHYX DELIVERY DEVICE, FASTENERS
AND ACCESSORIES 110
HELIOSPHERE BAG 111
HELIOGAST 111
Heliogast HAGE 111
Heliogast HAGA 111
ENDOCINCH 111
ENDOSURGICAL OPERATING SYSTEM (EOS) 112
ABANDONED PRODUCTS 112
GARREN-EDWARDS GASTRIC BUBBLE (GEGB) 112
TABLE 24 KEY ABANDONED/ DISCONTINUED PRODUCTS OF BARIATRIC SURGERY
DEVICES 113
EASYBAND 113
PIPELINE PRODUCTS 113
ENDOBARRIER 113
General Description 113
Procedure 114
Clinical Trials 114
TABLE 25 ENDOBARRIER CLINICAL TRIALS 114
Advantages 116
Disadvantages 117
HLC153B - Bariatric Surgery: Global Markets for Services and Devices
Copyright © BCC Research, Wellesley MA USA, Website: www.bccresearch.com
TOPIC PAGE NO.
EndoBarrier: Procedure Cost 117
TABLE 26 KEY PIPELINE PRODUCTS OF BARIATRIC SURGERY DEVICES 117
VALENTX 119
General Description 119
Clinical Trials 120
TABLE 27 VALENTX CLINICAL TRIALS 120
Advantages 121
ASPIREASSIST 121
General Description 121
Clinical Trials 121
TABLE 28 ASPIREASSIST CLINICAL TRIAL 122
Procedure 122
TANTALUS SYSTEM 122
General Description 122
Clinical Trials 123
TABLE 29 TANTALUS SYSTEM CLINICAL TRIAL 124
Procedure 125
DEEP BRAIN STIMULATION SYSTEM/TRIGEMINAL NERVE STIMULATION
(TNS)-OBESITY 125
General Description 125
Clinical Trials 126
TABLE 30 TRIGEMINAL NERVE STIMULATION (TNS) CLINICAL TRIAL 127
ELIPSE 127
General Description 127
Procedure 127
FULL SENSE DEVICE 127
General Description 127
Procedure 128
Clinical Trials 128
SAMSEN MAGNETS 128
General Description 128
Procedure 128
GASTRIC VEST SYSTEM 129
General Description 129
Procedure 129
OBALON BALLOON 129
General Description 129
Procedure 129
Clinical Trials 130
SMART DEVICE 130
General Description 130
Procedure 130
INTRAGASTRIC BALLOON 131
General Description 131
Procedure 131
DIGESTIBLE BALLOON 131
General Description 131
Clinical Trials 131
HLC153B - Bariatric Surgery: Global Markets for Services and Devices
Copyright © BCC Research, Wellesley MA USA, Website: www.bccresearch.com
TOPIC PAGE NO.
SPATZ3 ADJUSTABLE BALLOON SYSTEM 132
General Description 132
Procedure 132
Clinical Trials 132
ENDORETICS DEVICE 132
General Description 132
Procedure 132
ATTIVA 133
NOBESE DEVICE 133
General Description 133
Procedure 133
SATISPHERE 134
General Description 134
Clinical Trials 134
Procedure 134
SILIMED GASTRIC BALLOON 135
General Description 135
Procedure 135
Clinical Trial 135
TABLE 31 SILIMED GASTRIC BALLOON CLINICAL TRIAL 135
TRANSPYLORIC SHUTTLE 135
General Description 135
Clinical Trials 136
TABLE 32 TRANSPYLORIC SHUTTLE DEVICE CLINICAL TRIAL 136
Procedure 136
TOGA SYSTEM 136
General Description 136
Clinical Trials 137
TABLE 33 TOGA SYSTEM CLINICAL TRIALS 137
Procedure 137
SENSATE ANCHORED GASTRIC DEVICE 137
General Description 137
Procedure 138
Clinical Trial 138
TABLE 34 SENSATE ANCHORED GASTRIC DEVICE CLINICAL TRIAL 138
ABILITI 138
General Description 138
Clinical Trials 139
TABLE 35 ABILITI SYSTEM CLINICAL TRIALS 139
CHAPTER 11 REIMBURSEMENT 141
GENERAL REIMBURSEMENT CRITERIA 141
UNITED STATES 141
ICD-9-CM 142
TABLE 36 BARIATRIC SURGERY, INTERNATIONAL CLASSIFICATION OF DISEASES,
NINTH REVISION (ICD-9) CODES 142
TABLE 37 COVERED INPATIENT FACILITY ICD-9-CM PROCEDURE CODES 142
ICD-10 143
HLC153B - Bariatric Surgery: Global Markets for Services and Devices
Copyright © BCC Research, Wellesley MA USA, Website: www.bccresearch.com
TOPIC PAGE NO.
EUROPE 144
JAPAN 144
OTHER ASIA 145
CHAPTER 12 CONCLUSIONS: THE OUTLOOK FOR BARIATRIC SURGERY DEVICES 147
MAJOR DEVELOPMENTS THAT WILL INFLUENCE THE BARIATRIC SURGERY
MARKET 147
TECHNOLOGICAL DEVELOPMENTS 147
Adaptation of Minimally Invasive Techniques to New Types of
Surgical Procedures 147
Endoluminal Procedures 148
Gastric Stimulators 148
New Designs of Gastric Balloons 149
DEMOGRAPHIC AND ECONOMIC TRENDS 149
Growing Obesity Populations Worldwide 149
TABLE 38 TRENDS IN OBESITY COMPOSITION OF THE WORLD'S POPULATION,
THROUGH 2020 (MILLIONS) 150
TABLE 39 U.S. OBESITY AND SEVERE OBESITY VS GENERAL POPULATION,
THROUGH 2020 (MILLIONS) 150
Income Growth in Developing Markets 151
TABLE 40 TRENDS IN PER CAPITA REAL GDP GROWTH BY REGION, 2012-2015
(ANNUAL AVERAGE PERCENTAGE CHANGE) 151
CHANGING STRUCTURE OF THE HEALTH CARE INDUSTRY 151
Hospital Consolidation 151
Medical Tourism 152
Health Insurance Developments 152
LONG-TERM OUTLOOK FOR BARIATRIC SURGERY DEVICES AND SERVICES 152
CHAPTER 13 APPENDIX A: ABBREVIATIONS 155
CHAPTER 14 COMPANY PROFILES 158
ALLURION TECHNOLOGIES 158
A.M.I. (AGENCY FOR MEDICAL INNOVATIONS) 158
APOLLO ENDOSURGERY 158
APPLIED MEDICAL 159
ASPIRE BARIATRICS 159
BARONOVA 160
BAROSENSE (SUBSIDIARY OF BOSTON SCIENTIFIC) 160
BAXTER 161
BETA-STIM 161
BFKW 161
COOK GROUP 162
C.R. BARD 162
CROSPON 163
ENDOGASTRIC SOLUTIONS 163
ENDORETICS 163
ENDOBETIX 164
ENDOSPHERE 164
ENTEROMEDICS 164
ETHICON ENDO-SURGERY (SUBSIDIARY OF JOHNSON and JOHNSON) 165
GELESIS 165
GI DYNAMICS 166
GI WINDOWS 167
HELIOSCOPIE 167
INTRAPACE INC. 167
MEDTRONIC 168
METACURE 169
OBALON THERAPEUTICS 169
ONCIOMED 169
PLENSAT 170
RESHAPE MEDICAL 170
SARL COUSIN BIOTECH 170
SATIETY 171
SCIENTIFIC INTAKE 171
SENSATE 171
SILHOUETTE MEDICAL 172
SKLAR 172
SLIMEDICS 172
SPATZ FGIA 173
TRANSENTERIX 173
TULIP MEDICAL 173
USGI MEDICAL 174
VALENTX 174
W. L. GORE 175
CHAPTER 15 APPENDIX C: INDUSTRY AND PROFESSIONAL ORGANIZATIONS 177
THE AMERICAN SOCIETY FOR METABOLIC AND BARIATRIC SURGERY (ASMBS) 177
EUROPEAN ASSOCIATION FOR ENDOSCOPIC SURGERY (EAES) 177
INTERNATIONAL ASSOCIATION FOR THE STUDY OF OBESITY 177
INTERNATIONAL DIABETES FEDERATION (IDF) 178
INTERNATIONAL FEDERATION FOR THE SURGERY OF OBESITY AND METABOLIC
DISORDERS 178
INTERNATIONAL OBESITY TASK FORCE (IOTF) 178
OBESITY IN AMERICA 179
THE OBESITY SOCIETY 179
SOCIETY OF AMERICAN GASTROINTESTINAL ENDOSCOPIC SURGEONS (SAGES) 179
SOCIETY OF LAPAROENDOSCOPIC SURGEONS (SLS) 180

LIST OF TABLES

SUMMARY TABLE GLOBAL MARKET FOR BARIATRIC SURGERY BY REGION, THROUGH
2020 ($ MILLIONS) 7
TABLE 1 BMI CALCULATION 10
TABLE 2 BMI CATEGORIES BASED ON INCREASING HEALTH RISKS 11
TABLE 3 GLOBAL OBESE POPULATION AND SEVERE OBESE POPULATION VS.
GENERAL POPULATION, THROUGH 2014 (MILLIONS) 16
TABLE 4 U.S. OBESITY AND SEVERE OBESITY VS. GENERAL POPULATION, THROUGH
2014 (MILLIONS) 17
TABLE 5 GLOBAL DIABETES PREVALENCE, THROUGH 2030 (BILLIONS/%/MILLIONS) 27
TABLE 6 TYPES OF BARIATRIC SURGERIES 36
TABLE 7 GLOBAL BARIATRIC PROCEDURES, THROUGH 2014 (NUMBER) 58
TABLE 8 BARIATRIC PROCEDURE OCCURRENCE IN NORTH AMERICA, THROUGH 2014
(NO. OF PROCEDURES) 60
TABLE 9 AVERAGE COST OF BARIATRIC SURGERY BY PROCEDURE TYPE ($) 61
TABLE 10 COMPARATIVE ANALYSIS OF BARIATRIC SURGERY 63
TABLE 11 PRINCIPAL TYPES OF BARIATRIC SURGERY DEVICES 67
TABLE 12 GLOBAL BARIATRIC PROCEDURE OCCURRENCE BY TYPE, THROUGH 2020
(NUMBER) 81
TABLE 13 BARIATRIC PROCEDURE OCCURRENCE BY REGION, THROUGH 2020
(NUMBER) 82
TABLE 14 BARIATRIC PROCEDURE OCCURRENCE IN NORTH AMERICA, THROUGH
2020 (NUMBER) 84
TABLE 15 BARIATRIC PROCEDURE OCCURRENCE IN EUROPE, THROUGH 2020
(NUMBER) 85
TABLE 16 BARIATRIC PROCEDURE OCCURRENCE IN ASIA, THROUGH 2020 (NUMBER) 87
TABLE 17 GLOBAL BARIATRIC SURGERY DEVICE MARKET BY REGION, THROUGH
2020 ($ MILLIONS) 89
TABLE 18 NORTH AMERICAN BARIATRIC SURGERY MARKET BY DEVICE TYPE,
THROUGH 2020 ($ MILLIONS) 90
TABLE 19 ASIAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, THROUGH 2020 ($
MILLIONS) 92
TABLE 20 EUROPEAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, THROUGH
2020 ($ MILLIONS) 93
TABLE 21 GLOBAL MARKET FOR IMPLANTED DEVICES, THROUGH 2020 ($ MILLIONS) 95
TABLE 22 GLOBAL BARIATRIC SURGERY MARKET SHARES BY COMPANY, 2014 ($
MILLIONS/%) 99
TABLE 23 KEY MARKETED PRODUCTS OF BARIATRIC SURGERY DEVICES 102
TABLE 24 KEY ABANDONED/ DISCONTINUED PRODUCTS OF BARIATRIC SURGERY
DEVICES 113
TABLE 25 ENDOBARRIER CLINICAL TRIALS 114
TABLE 26 KEY PIPELINE PRODUCTS OF BARIATRIC SURGERY DEVICES 117
TABLE 27 VALENTX CLINICAL TRIALS 120
TABLE 28 ASPIREASSIST CLINICAL TRIAL 122
TABLE 29 TANTALUS SYSTEM CLINICAL TRIAL 124
TABLE 30 TRIGEMINAL NERVE STIMULATION (TNS) CLINICAL TRIAL 127
TABLE 31 SILIMED GASTRIC BALLOON CLINICAL TRIAL 135
TABLE 32 TRANSPYLORIC SHUTTLE DEVICE CLINICAL TRIAL 136
TABLE 33 TOGA SYSTEM CLINICAL TRIALS 137
TABLE 34 SENSATE ANCHORED GASTRIC DEVICE CLINICAL TRIAL 138
TABLE 35 ABILITI SYSTEM CLINICAL TRIALS 139
TABLE 36 BARIATRIC SURGERY, INTERNATIONAL CLASSIFICATION OF DISEASES,
NINTH REVISION (ICD-9) CODES 142
TABLE 37 COVERED INPATIENT FACILITY ICD-9-CM PROCEDURE CODES 142
TABLE 38 TRENDS IN OBESITY COMPOSITION OF THE WORLD'S POPULATION,
THROUGH 2020 (MILLIONS) 150
TABLE 39 U.S. OBESITY AND SEVERE OBESITY VS GENERAL POPULATION, THROUGH
2020 (MILLIONS) 150
TABLE 40 TRENDS IN PER CAPITA REAL GDP GROWTH BY REGION, 2012-2015
(ANNUAL AVERAGE PERCENTAGE CHANGE) 151

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the ...

Cardiovascular Surgical Devices: Technologies and Global Markets

Cardiovascular Surgical Devices: Technologies and Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about the trends and developments affecting each type of cardiovascular surgical technology - Analyze trends and opportunities in major regions: North America, Europe, Asia ...

TCR/CAR-T Therapies in Oncology: Analytical Tool

TCR/CAR-T Therapies in Oncology: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.